Roquette will showcase its expanded consumer healthcare portfolio at Vitafoods Europe 2026 [1].

This move signals a strategic shift toward plant-based pharmaceutical solutions, reflecting a growing global demand for natural ingredients in everyday health products. By expanding its capabilities, Roquette aims to bridge the gap between industrial plant-based chemistry and consumer-ready healthcare innovations.

The event is scheduled to take place from May 5 to May 7 [1]. The company will present a range of plant-based ingredients, excipients, and pharmaceutical solutions.

There is a conflicting report regarding the exact location of the company's presence. While some reports state the event takes place in Barcelona [1], others mention booth 3F112 in Lille, France [1]. This discrepancy suggests a possible dual-presence or a logistical error in the company's announcement.

Roquette, a global leader in plant-based ingredients and pharmaceutical solutions, intends to use the exhibition to share insights on consumer-ready innovations for everyday health [1]. The company's expanded portfolio is designed to meet the evolving needs of the consumer healthcare market, focusing on plant-based alternatives to synthetic pharmaceutical excipients.

As the plant-based sector continues to evolve, the company's focus on pharmaceutical solutions suggests a move toward higher-value pharmaceutical grade ingredients. This shift is an attempt to integrate plant-based chemistry into pharmaceutical standards.

Roquette will continue to showcase its expanded capabilities to industry experts and partners at the event.

“Roquette will showcase its expanded consumer healthcare portfolio at Vitafoods Europe 2026.”

The expansion of Roquette's portfolio at Vitafoods Europe 2026 indicates a trend toward the 'medicalization' of plant-based ingredients. By shifting focus from food-grade to pharmaceutical-grade plant-based excipients, the company is positioning itself to capture a growing market for natural, clean-label pharmaceutical products that meet strict regulatory standards.